{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:05Z","timestamp":1707523925487},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,19]]},"DOI":"10.7759\/cureus.45521","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T09:07:51Z","timestamp":1695114471000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Primary Sjogren\u2019s Syndrome Coexisting With Gilbert Syndrome"],"prefix":"10.7759","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leixi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert's syndrome","volume":"55","author":"Wagner KH","year":"2018","unstructured":"Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci. 2018, 55:129-139. 10.1080\/10408363.2018.1428526","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9219","article-title":"Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: a case report","volume":"20","author":"Ye N","year":"2020","unstructured":"Ye N, Zhou Z, Gong H, Teng J, Han Y, Yang C, Ye J. Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: a case report. Exp Ther Med. 2020, 20:91. 10.3892\/etm.2020.9219","journal-title":"Exp Ther Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2018.000028","article-title":"Overview of Gilbert's syndrome","volume":"57","author":"King D","year":"2019","unstructured":"King D, Armstrong MJ. Overview of Gilbert's syndrome. Drug Ther Bull. 2019, 57:27-31. 10.1136\/dtb.2018.000028","journal-title":"Drug Ther Bull"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1258\/000456306778520034","article-title":"Gilbert's syndrome: an overview for clinical biochemists","volume":"43","author":"Hirschfield GM","year":"2006","unstructured":"Hirschfield GM, Alexander GJ. Gilbert's syndrome: an overview for clinical biochemists. Ann Clin Biochem. 2006, 43:340-343. 10.1258\/000456306778520034","journal-title":"Ann Clin Biochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2013.01.003","article-title":"Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database","volume":"50","author":"Canu G","year":"2013","unstructured":"Canu G, Minucci A, Zuppi C, Capoluongo E. Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database. Blood Cells Mol Dis. 2013, 50:273-280. 10.1016\/j.bcmd.2013.01.003","journal-title":"Blood Cells Mol Dis"},{"key":"ref6","article-title":"(TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome","volume":"84","author":"Iolascon A","year":"1999","unstructured":"Iolascon A, Faienza MF, Centra M, Storelli S, Zelante L, Savoia A. (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica. 1999, 84:106-109.","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328256b1b6","article-title":"Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates","volume":"17","author":"Udomuksorn W","year":"2007","unstructured":"Udomuksorn W, Elliot DJ, Lewis BC, Mackenzie PI, Yoovathaworn K, Miners JO. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics. 2007, 17:1017-1029. 10.1097\/FPC.0b013e328256b1b6","journal-title":"Pharmacogenet Genomics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.06.016","article-title":"Liver abnormalities in connective tissue diseases","volume":"27","author":"De Santis M","year":"2013","unstructured":"De Santis M, Crotti C, Selmi C. Liver abnormalities in connective tissue diseases. Best Pract Res Clin Gastroenterol. 2013, 27:543-551. 10.1016\/j.bpg.2013.06.016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23090","article-title":"Clinical significance of serum bilirubin in primary Sj\u00f6gren syndrome patients","volume":"34","author":"Zhang Z","year":"2020","unstructured":"Zhang Z, Su Q, Zhang L, Yang Z, Qiu Y, Mo W. Clinical significance of serum bilirubin in primary Sj\u00f6gren syndrome patients. J Clin Lab Anal. 2020, 34:e23090. 10.1002\/jcla.23090","journal-title":"J Clin Lab Anal"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.047","article-title":"Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences","volume":"146","author":"Erlinger S","year":"2014","unstructured":"Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. 2014, 146:1625-1638. 10.1053\/j.gastro.2014.03.047","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328012d0da","article-title":"Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter","volume":"17","author":"Hsieh TY","year":"2007","unstructured":"Hsieh TY, Shiu TY, Huang SM, et al.. Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter. Pharmacogenet Genomics. 2007, 17:229-236. 10.1097\/FPC.0b013e328012d0da","journal-title":"Pharmacogenet Genomics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008620","article-title":"Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II","volume":"96","author":"Sun L","year":"2017","unstructured":"Sun L, Li M, Zhang L, et al.. Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II. Medicine (Baltimore). 2017, 96:e8620. 10.1097\/MD.0000000000008620","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s100380050050","article-title":"Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II","volume":"43","author":"Yamamoto K","year":"1998","unstructured":"Yamamoto K, Soeda Y, Kamisako T, et al.. Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998, 43:111-114. 10.1007\/s100380050050","journal-title":"J Hum Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/635126","article-title":"Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study","volume":"23","author":"Minuk GY","year":"2009","unstructured":"Minuk GY, Greenberg R, Uhanova J, Hawkins K, Leslie WD. Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol. 2009, 23:431-436. 10.1155\/2009\/635126","journal-title":"Can J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24605","article-title":"Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases","volume":"54","author":"Ruiz-Gasp\u00e0 S","year":"2011","unstructured":"Ruiz-Gasp\u00e0 S, Martinez-Ferrer A, Gua\u00f1abens N, et al.. Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases. Hepatology. 2011, 54:2104-2113. 10.1002\/hep.24605","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12355","article-title":"Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis","volume":"44","author":"Ruiz-Gasp\u00e0 S","year":"2014","unstructured":"Ruiz-Gasp\u00e0 S, Dubreuil M, Gua\u00f1abens N, Combalia A, Peris P, Monegal A, Par\u00e9s A. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis. Eur J Clin Invest. 2014, 44:1206-1214. 10.1111\/eci.12355","journal-title":"Eur J Clin Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.144167","article-title":"Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases","volume":"725","author":"Ruiz-Gasp\u00e0 S","year":"2020","unstructured":"Ruiz-Gasp\u00e0 S, Gua\u00f1abens N, Jurado S, et al.. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases. Gene. 2020, 725:144167. 10.1016\/j.gene.2019.144167","journal-title":"Gene"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116483","article-title":"Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases","volume":"162","author":"Jurado S","year":"2022","unstructured":"Jurado S, Par\u00e9s A, Peris P, Combalia A, Monegal A, Gua\u00f1abens N. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases. Bone. 2022, 162:116483. 10.1016\/j.bone.2022.116483","journal-title":"Bone"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2010.05.030","article-title":"Liver and bone","volume":"503","author":"Gua\u00f1abens N","year":"2010","unstructured":"Gua\u00f1abens N, Par\u00e9s A. Liver and bone. Arch Biochem Biophys. 2010, 503:84-94. 10.1016\/j.abb.2010.05.030","journal-title":"Arch Biochem Biophys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100114","article-title":"Patients with Gilbert syndrome and type 2 diabetes have lower prevalence of microvascular complications","volume":"11","author":"Uribe-Weichers AC","year":"2021","unstructured":"Uribe-Weichers AC, G\u00f3mez-P\u00e9rez FJ, Lam-Chung CE, Cuevas-Ramos D. Patients with Gilbert syndrome and type 2 diabetes have lower prevalence of microvascular complications. Metabol Open. 2021, 11:100114. 10.1016\/j.metop.2021.100114","journal-title":"Metabol Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/169537-a-rare-case-of-primary-sjogrens-syndrome-coexisting-with-gilbert-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:04Z","timestamp":1707508444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/169537-a-rare-case-of-primary-sjogrens-syndrome-coexisting-with-gilbert-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.45521","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,19]]}}}